Maio M - Search Results

1

CD40 expression by human melanocytic lesions and melanoma cell lines and direct CD40 targeting with the therapeutic anti-CD40 antibody CP-870,893.

Kalbasi A, Fonsatti E, Natali PG, Altomonte M, Bertocci E, Cutaia O, Calabrò L, Chiou M, Tap W, Chmielowski B, Maio M, Ribas A. Kalbasi A, et al. Among authors: maio m. J Immunother. 2010 Oct;33(8):810-6. doi: 10.1097/CJI.0b013e3181ee73a7. J Immunother. 2010. PMID: 20842056

2

Recombinant transmembrane CD59 (CD59-TM) confers complement resistance to GPI-anchored protein defective melanoma cells.

De Nardo C, Fonsatti E, Sigalotti L, Calabrò L, Colizzi F, Cortini E, Coral S, Altomonte M, Maio M. De Nardo C, et al. Among authors: maio m. J Cell Physiol. 2002 Feb;190(2):200-6. doi: 10.1002/jcp.10050. J Cell Physiol. 2002. PMID: 11807824

3

Vaccination of stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells.

Maio M, Fonsatti E, Lamaj E, Altomonte M, Cattarossi I, Santantonio C, Melani C, Belli F, Arienti F, Colombo MP, Parmiani G. Maio M, et al. Cancer Immunol Immunother. 2002 Mar;51(1):9-14. doi: 10.1007/s00262-001-0249-z. Epub 2001 Dec 18. Cancer Immunol Immunother. 2002. PMID: 11845255 Free PMC article. Clinical Trial.

4

Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanoma.

Sigalotti L, Coral S, Nardi G, Spessotto A, Cortini E, Cattarossi I, Colizzi F, Altomonte M, Maio M. Sigalotti L, et al. Among authors: maio m. J Immunother. 2002 Jan-Feb;25(1):16-26. doi: 10.1097/00002371-200201000-00002. J Immunother. 2002. PMID: 11924907

5

5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications.

Coral S, Sigalotti L, Altomonte M, Engelsberg A, Colizzi F, Cattarossi I, Maraskovsky E, Jager E, Seliger B, Maio M. Coral S, et al. Among authors: maio m. Clin Cancer Res. 2002 Aug;8(8):2690-5. Clin Cancer Res. 2002. PMID: 12171902

6

European approach to antibody-based immunotherapy of melanoma.

Altomonte M, Maio M. Altomonte M, et al. Among authors: maio m. Semin Oncol. 2002 Oct;29(5):471-8. doi: 10.1053/sonc.2002.35242. Semin Oncol. 2002. PMID: 12407512 Review.

7

Differential levels of soluble endoglin (CD105) in myeloid malignancies.

Calabrò L, Fonsatti E, Bellomo G, Alonci A, Colizzi F, Sigalotti L, Altomonte M, Musolino C, Maio M. Calabrò L, et al. Among authors: maio m. J Cell Physiol. 2003 Feb;194(2):171-5. doi: 10.1002/jcp.10200. J Cell Physiol. 2003. PMID: 12494455

8

Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1.

Maio M, Coral S, Sigalotti L, Elisei R, Romei C, Rossi G, Cortini E, Colizzi F, Fenzi G, Altomonte M, Pinchera A, Vitale M. Maio M, et al. J Clin Endocrinol Metab. 2003 Feb;88(2):748-54. doi: 10.1210/jc.2002-020830. J Clin Endocrinol Metab. 2003. PMID: 12574209

9

Methylation-regulated expression of HLA class I antigens in melanoma.

Fonsatti E, Sigalotti L, Coral S, Colizzi F, Altomonte M, Maio M. Fonsatti E, et al. Among authors: maio m. Int J Cancer. 2003 Jun 20;105(3):430-1; author reply 432-3. doi: 10.1002/ijc.11077. Int J Cancer. 2003. PMID: 12704681 No abstract available.

10

Epigenetic targets for immune intervention in human malignancies.

Maio M, Coral S, Fratta E, Altomonte M, Sigalotti L. Maio M, et al. Oncogene. 2003 Sep 29;22(42):6484-8. doi: 10.1038/sj.onc.1206956. Oncogene. 2003. PMID: 14528272 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,071 results

Search Page

Filters